People with HIV who switched from bictegravir to injectable cabotegravir and rilpivirine rarely experienced substantial changes in body weight, Dr Darrell Tan of St Michael’s Hospital, Toronto, reported at the 2023 Conference on Retroviruses and Opportunistic…